“For nuclear medicine to be widely successful you have to care about people everywhere. We need to come up with solutions that make nuclear medicine really accessible for everyone. And the reason why we should do that is because it has a great cost beneficial profile”. The serial entrepreneur Dr Christian Behrenbruch is co-founder and CEO of Telix Pharmaceuticals and our guest in this episode of Theragnostic Talks. Enjoy!

Guest: Dr Christian Behrenbruch